Life Sciences, funding, Venture Capital
Femta Raises $1M
Bruce V. Bigelow 7/17/09
Femta Pharmaceuticals, a San Diego biotech developing a new generation of antibody therapeutics, is raising $1 million in venture captial, according to a recent filing with government regulators. Investors were not disclosed in the filing, although San Francisco’s Latterell Venture Partners identifies Femta as one of its portfolio companies. Femta was founded last year.
Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call 858-202-0492
